The impact of COVID-19 pandemic on invasive fungal infections in Africa: What have we learned?
PLoS Negl Trop Dis
; 16(8): e0010720, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-2021516
ABSTRACT
Invasive fungal infections (IFIs) have been described as diseases of the poor. The mortality rate of the infections is comparable to that of malaria, HIV, and TB, yet the infections remain poorly funded, neglected in research, and policy at all levels of human resources. The Coronavirus Disease 2019 (COVID-19) pandemic has further worsened the current state of management for IFIs. At the same time, response to COVID-19 has stirred and boosted vaccine production, vaccine substance manufacturing, and building of next-generation sequencing capacity and genomics data sharing network in the continent. Through collaboration and transdisciplinary research effort, these network and technology can be extended to encourage fungal research to address health issues of existing and emerging fungal pathogens.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Invasive Fungal Infections
/
COVID-19
/
Malaria
Type of study:
Experimental Studies
/
Observational study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Africa
Language:
English
Journal:
PLoS Negl Trop Dis
Journal subject:
Tropical Medicine
Year:
2022
Document Type:
Article
Affiliation country:
Journal.pntd.0010720
Similar
MEDLINE
...
LILACS
LIS